*Ihetic valves, homografts offer the advantages of central turbulance-free flow characteristics, absence of haemolysis (Yacoub et al., , I969) , freedom from thromboembolic complications (McDonald et al., I968) , and an X insignificant gradient across the valve. A change in heart size, as measured on the plain -,chest radiograph, is a useful objective method of evaluating cardiac response to valve replacement. The variable effects of insertion of prosthetic valves on heart size have been reported (Rastelli, Kincaid, and Kirklin, I966) . The purpose of this paper is to study changes in heart size after homograft replacement of the '..aortic, mitral, or both valves, and to attempt to explain the different response in each group.
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Patients and methods
Sixty-nine consecutive patients who survived homograft replacement of one or more valves were followed up for a minimum period of three months. All patients had severe lesions of mitral, aortic, or both valves, and were significantly incapacitated. Thirty patients (21 men and 9 women ranging in age between 24 and 62 years) had aortic valve replacement; 25 patients (17 men and 8 women ranging in age between 30 and 66 years) had mitral valve replacement, and 14 patients (8 men and 6 women ranging in age between 43 and 59 years) had both aortic and mitral valve replacement. For aortic valve replacement, the valves were inserted in the subcoronary position using two suture lines, a lower interrupted and an upper continuous (Ross and Yacoub, I969) . For mitral valve replacement, a fresh semilunar valve homograft, supported by a Dacron tube, was inserted in the left atrium using autogenous pericardium to refashion a new floor for the left atrium (Yacoub and Kittle, I969, I970) . All films were taken in full inspiration at a standard distance of 6 feet in the posteroanterior projection. Each film was examined critically by two independent observers, and unsuitable films were excluded. The main reasons for exclusion were as follows.
(i) Incomplete inspiration with a resulting high diaphragm. (2) An indistinct outer border of the heart which could not be accurately delineated.
(3) In the largest hearts the lateral border of the cardiac shadow was confluent with the rib cage, and so the cardiac size could not be estimated.
The postoperative films were taken a minimum of 3 months and a maximum of I9 months after operation.
The cardiothoracic index was calculated by measuring the greatest horizontal width of the cardiac shadow and the maximal indirect internal thoracic diameter (Fig. I) .
Both the cardiothoracic index and the greatest horizontal width of the heart were taken into consideration in the assessment of results, as they provide a simple and widely used method of evaluating heart size and, more indirectly, of assessing changes in cardiac volume. Keats and Enge (I965) have described a more detailed method of measuring cardiac volumes by simple radiographic techniques, but this method also is not free from error.
In patients with aortic valve replacement the mean interval was IO months and 13 days, in mitral valve replacement 8 months and 22 days, and in double valve replacement 8 months and 25 days.
The values obtained for the cardiothoracic index and the heart size (in cm) were analysed statistically by using the Student's t test on the difference between individual pairs of readings taken before and after operation.
Results
Changes in the cardiothoracic index and individual changes in heart size for the three groups of patients are shown in Fig. 2 and 3 , and the mean changes in cardiothoracic index and heart size are represented graphically in Fig. 4 (Rastelli et al., I966) . The average reduction in cardiothoracic index after homograft replacement of the aortic valve in our series was 9-2 per cent as compared to 9 per cent after prosthetic replacement of the aortic valve (Rastelli et al., I966) . In our series, 88 per cent of the patients showed reduction in cardiothoracic index after homograft replacement of the mitral valve as compared to 50 per cent of a group of patients who underwent prosthetic replacement of the mitral valve at the Mayo Clinic (Rastelli et al., I966) . The average reduction in cardiothoracic index after homograft replacement of the mitral valve in our series was 3-2 per cent as compared to 2 per cent after prosthetic mitral valve replacement (Rastelli et al., I966) .
Patients with aortic and mitral valve disease had the highest cardiothoracic index preoperatively. With two exceptions, all these patients showed decrease in heart size after homograft replacement of the aortic and mitral valve, with a mean reduction in cardiothoracic index of IO07 per cent Discussion Any reduction in the width of the heart reflects a much greater reduction in its volume. This is illustrated by the fact that a IO per cent reduction in the diameter of a sphere will reduce its volume by approximately 27 per cent. Therefore an average reduction of 9.4 per cent or ii per cent after aortic or double valve replacement, respectively, represents a considerable reduction in cardiac volume and, in some cases, may reduce the heart size to within normal limits.
The difference in the response in the heart size after homograft replacement compared to that after prosthetic valve replacement is probably due to the better flow characteristics of a homograft valve and the fact that the rigid intracardiac prosthetic material may interfere with normal cardiac function.
The lesser reduction in heart size after replacement of the mitral valve compared to that after aortic valve replacement, in this series, is similar to that observed by Rastelli et al. (I966) after prosthetic valve replacement. This may be due to the fact that most patients with severe mitral valve disease have impairment of myocardial function from previous rheumatic myocarditis or secondary to hypoperfusion due to the low cardiac output state known to occur in these patients (Judson et al., I964; Austen et al., I966; Rastelli and Kirklin, I966; Rouleau, Frye, and Ellis, I969). In addition, many patients with mitral valve disease have gross enlargement of the left atrium, atrial fibrillation, pulmonary vascular disease, and/or tricuspid valve disease. These factors tend to persist after valve replacement and may be responsible for the persistence of the cardiac enlargement. Over 50 per cent of patients with isolated aortic valve disease in our series were found at operation to have a congenitally abnormal valve (nonrheumatic). These patients usually remain in sinus rhythm and do not have any intrinsic myocardial disease, which explains why they respond with conspicuous reduction in their heart size after valve replacement, In spite of the presence of severe mitral disease and the associated adverse factors, it is surprising that the reduction in heart size after homograft replacement of both aortic and mitral valves is much greater than that after isolated mitral valve replacement.
In this series, 9 patients preoperatively had a pulmonary vascular resistance of more than 5 units and 4 of these showed an increase in heart size after replacement of one or more valves. A high pulmonary vascular resistance may therefore be one of the important factors in the persistence of cardiac enlargement postoperatively.
